Skip to search formSkip to main contentSkip to account menu

oxolamine

Known as: 5-(2-(diethylamino)ethyl)-3-phenyl-1,2,4-oxadiazole, 5-diethylaminoethyl-3-phenyl-1,2,4-oxadiazole 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

Antitussive AgentsOxadiazoles

Narrower (2)

Bredonoxolamine citrate
Chlorpheniramine / Ephedrine / oxolamine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
NEW SPECTROPHOTOMETRIC METHODS FOR THE QUANTITATIVE ESTIMATION OF OXOLAMINE IN FORMULATION
Five simple, sensitive and economical spectrophotometric methods have been developed for the determination of Oxolamine in… 
2012
2012
Screening of differentially expressed genes and small molecule drugs of pediatric allergic asthma with DNA microarray.
BACKGROUND Asthma is a disease resulting from a complex interaction of multiple genetic and environmental factors. More than 200… 
1989
1989
Occupational allergic contact dermatitis from oxolamine
1989
1989
Stability of oxolamine in aqueous solutions
1986
1986
Ion pair spectrophotometric assay of oxolamine
1978
1978
Long-term safety evaluation of 3-phenyl-5beta diethylaminoethyl-1,2,4-oxadiazole. II. In rhesus monkeys.
1962
1962
The treatment of tracheo-bronchial inflammation with oxolamine.
1962
1962
Elimination of oxolamine in rat and in human beings.
1961
1961
Pharmacological properties of 3-phenyl-5beta diethylaminoethyl-1,2,4-oxadiazole.
The general pharmacological properties of Oxolamine (3-phenyl-5beta-diethylaminoethyl-1,2,4-oxadiazole) are described. The… 
1961
1961
[The recent introduction in therapy of a new antitussive drug: oxolamine].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)